Cargando…
Prostatic Leiomyosarcoma: The Case for Combined Modality Therapy
Patient. A 65-year old man who had previously undergone surgery for benign prostatic hyperplasia presented with symptoms of recurrent bladder outflow obstruction. Cystoscopy revealed the presence of recurrent tissue. Results. Histology identified a leiomyosarcoma. Several years after further surgery...
Autores principales: | , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
1997
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2373583/ https://www.ncbi.nlm.nih.gov/pubmed/18521202 http://dx.doi.org/10.1080/13577149778498 |
_version_ | 1782154380523339776 |
---|---|
author | El-Sharkawi, Salah Vaughton, Keith |
author_facet | El-Sharkawi, Salah Vaughton, Keith |
author_sort | El-Sharkawi, Salah |
collection | PubMed |
description | Patient. A 65-year old man who had previously undergone surgery for benign prostatic hyperplasia presented with symptoms of recurrent bladder outflow obstruction. Cystoscopy revealed the presence of recurrent tissue. Results. Histology identified a leiomyosarcoma. Several years after further surgery and radiotherapy, the patient presented with secondaries in the lungs and brain, but there was no evidence of local recurrence. Discussion. It is suggested that combined modality therapy (conservative surgical resection followed by adjuvant radical radiotherapy) be the initial treatment for prostatic leiomyosarcoma. |
format | Text |
id | pubmed-2373583 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 1997 |
publisher | Hindawi Publishing Corporation |
record_format | MEDLINE/PubMed |
spelling | pubmed-23735832008-06-02 Prostatic Leiomyosarcoma: The Case for Combined Modality Therapy El-Sharkawi, Salah Vaughton, Keith Sarcoma Research Article Patient. A 65-year old man who had previously undergone surgery for benign prostatic hyperplasia presented with symptoms of recurrent bladder outflow obstruction. Cystoscopy revealed the presence of recurrent tissue. Results. Histology identified a leiomyosarcoma. Several years after further surgery and radiotherapy, the patient presented with secondaries in the lungs and brain, but there was no evidence of local recurrence. Discussion. It is suggested that combined modality therapy (conservative surgical resection followed by adjuvant radical radiotherapy) be the initial treatment for prostatic leiomyosarcoma. Hindawi Publishing Corporation 1997-03 /pmc/articles/PMC2373583/ /pubmed/18521202 http://dx.doi.org/10.1080/13577149778498 Text en Copyright © 1997 Hindawi Publishing Corporation. http://creativecommons.org/licenses/by/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article El-Sharkawi, Salah Vaughton, Keith Prostatic Leiomyosarcoma: The Case for Combined Modality Therapy |
title | Prostatic Leiomyosarcoma: The Case for Combined Modality Therapy |
title_full | Prostatic Leiomyosarcoma: The Case for Combined Modality Therapy |
title_fullStr | Prostatic Leiomyosarcoma: The Case for Combined Modality Therapy |
title_full_unstemmed | Prostatic Leiomyosarcoma: The Case for Combined Modality Therapy |
title_short | Prostatic Leiomyosarcoma: The Case for Combined Modality Therapy |
title_sort | prostatic leiomyosarcoma: the case for combined modality therapy |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2373583/ https://www.ncbi.nlm.nih.gov/pubmed/18521202 http://dx.doi.org/10.1080/13577149778498 |
work_keys_str_mv | AT elsharkawisalah prostaticleiomyosarcomathecaseforcombinedmodalitytherapy AT vaughtonkeith prostaticleiomyosarcomathecaseforcombinedmodalitytherapy |